Literature DB >> 19938135

Acute kidney injury during liver transplantation as determined by neutrophil gelatinase-associated lipocalin.

Claus U Niemann1, Ann Walia, Jeffrey Waldman, Michael Davio, John P Roberts, Ryutaro Hirose, John Feiner.   

Abstract

Acute kidney injury (AKI) has significant prognostic implications for long-term outcomes in patients undergoing liver transplantation. In several retrospective studies, perioperative variables have been associated with AKI. These variables have been mainly associated with changes in creatinine concentrations over several days or months post-transplantation. To better define AKI, new markers have become available that help to identify patients at risk for renal injury within hours of a triggering insult. We prospectively enrolled liver transplant patients at our institutions to evaluate neutrophil gelatinase-associated lipocalin (NGAL), a marker of early renal injury, as a surrogate for AKI in patients undergoing liver transplantation. Blood was prospectively collected at predetermined time points from 59 patients at 2 institutions. The electronic anesthesia records and the hospital computer data system were reviewed for perioperative variables. Data collection included patient demographics, intraoperative variables such as fluid management, transfusion requirements, hemodynamics, and urine output. Subsequently, patients were grouped according to the presence of risk for developing AKI as defined by the RIFLE (risk, injury, failure, loss, and end-stage kidney disease) criteria. The difference between the NGAL concentration 2 hours after reperfusion and the baseline NGAL concentration was predictive of AKI in all patients, including patients with preexisting renal dysfunction. In patients with creatinine concentrations less than 1.5 mg/dL, a single NGAL determination 2 hours after reperfusion of the liver was associated with the development of AKI. Total occlusion of the inferior vena cava was associated with AKI. In conclusion, NGAL concentrations obtained during surgery were highly associated with postoperative AKI in patients undergoing liver transplantation. These findings will allow the design of larger interventional studies. Our findings regarding the impact of surgical techniques and glucose require validation in larger studies.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19938135     DOI: 10.1002/lt.21938

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  34 in total

1.  Elevated serum neutrophil gelatinase-associated lipocalin is an early predictor of severity and outcome in acute pancreatitis.

Authors:  Subhankar Chakraborty; Sukhwinder Kaur; Venkata Muddana; Neil Sharma; Uwe A Wittel; Georgios I Papachristou; David Whitcomb; Randall E Brand; Surinder K Batra
Journal:  Am J Gastroenterol       Date:  2010-02-23       Impact factor: 10.864

Review 2.  Proteomic biomarkers in kidney disease: issues in development and implementation.

Authors:  Harald Mischak; Christian Delles; Antonia Vlahou; Raymond Vanholder
Journal:  Nat Rev Nephrol       Date:  2015-02-03       Impact factor: 28.314

3.  Early Postoperative Neutrophil Gelatinase-Associated Lipocalin Predicts the Development of Chronic Kidney Disease After Liver Transplantation.

Authors:  Giuseppe Cullaro; Joseph F Pisa; Robert S Brown; Gebhard Wagener; Elizabeth C Verna
Journal:  Transplantation       Date:  2018-05       Impact factor: 4.939

4.  Clinical and plasma proteomic markers correlating with chronic kidney disease after liver transplantation.

Authors:  J Levitsky; D R Salomon; M Abecassis; P Langfelder; S Horvath; J Friedewald; E Wang; S M Kurian; T Mondala; S Gil; R McDade; K Ballard; L Gallon
Journal:  Am J Transplant       Date:  2011-07-27       Impact factor: 8.086

Review 5.  Biomarkers for the early detection of acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Curr Opin Pediatr       Date:  2011-04       Impact factor: 2.856

6.  Urinary neutrophil gelatinase-associated lipocalin as a marker of acute kidney injury after orthotopic liver transplantation.

Authors:  Gebhard Wagener; Moury Minhaz; Fallon A Mattis; Mihwa Kim; Jean C Emond; H Thomas Lee
Journal:  Nephrol Dial Transplant       Date:  2011-01-21       Impact factor: 5.992

Review 7.  Neutrophil gelatinase-associated lipocalin: a promising biomarker for human acute kidney injury.

Authors:  Prasad Devarajan
Journal:  Biomark Med       Date:  2010-04       Impact factor: 2.851

8.  α-Intercalated cells defend the urinary system from bacterial infection.

Authors:  Neal Paragas; Ritwij Kulkarni; Max Werth; Kai M Schmidt-Ott; Catherine Forster; Rong Deng; Qingyin Zhang; Eugenia Singer; Alexander D Klose; Tian Huai Shen; Kevin P Francis; Sunetra Ray; Soundarapandian Vijayakumar; Samuel Seward; Mary E Bovino; Katherine Xu; Yared Takabe; Fábio E Amaral; Sumit Mohan; Rebecca Wax; Kaitlyn Corbin; Simone Sanna-Cherchi; Kiyoshi Mori; Lynne Johnson; Thomas Nickolas; Vivette D'Agati; Chyuan-Sheng Lin; Andong Qiu; Qais Al-Awqati; Adam J Ratner; Jonathan Barasch
Journal:  J Clin Invest       Date:  2014-06-17       Impact factor: 14.808

Review 9.  Renal dysfunction in chronic liver disease.

Authors:  Andy Slack; Andrew Yeoman; Julia Wendon
Journal:  Crit Care       Date:  2010-03-09       Impact factor: 9.097

Review 10.  Protecting the Kidney in Liver Transplant Recipients: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.

Authors:  J Levitsky; J G O'Leary; S Asrani; P Sharma; J Fung; A Wiseman; C U Niemann
Journal:  Am J Transplant       Date:  2016-04-22       Impact factor: 8.086

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.